Related Experiment Video

Updated: Jun 24, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in

Jianhua Yu1, Maxim Ershler, Li Yu

  • 1Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA. jianhua.yu@osumc.edu

Blood
|March 31, 2009
PubMed

Insights

Tumor suppressor gene TSC-22 is silenced by methylation in mouse leukemia, impacting hematopoietic precursor cells. Therapy reversed silencing, improving survival and delaying tumor growth, suggesting TSC-22

Area of Science:

  • Oncology
  • Epigenetics
  • Hematology

Background:

  • Aberrant methylation silences tumor suppressor genes in various cancers.
  • The function and silencing mechanisms of TSC-22 remain largely uncharacterized.
  • TSC-22 is known to be silenced in several types of solid tumors.

Purpose of the Study:

  • To investigate the role of TSC-22 methylation in T or natural killer (NK) large granular lymphocyte (LGL) leukemia.
  • To explore the therapeutic potential of reversing TSC-22 silencing.
  • To elucidate the function of TSC-22 in hematopoietic precursor cells (HPCs).

Main Methods:

  • Analysis of TSC-22 promoter methylation in primary mouse T or NK LGL leukemia.
  • In vivo treatment with 5-aza-2'-deoxycytidine to reverse TSC-22 silencing.
  • Assessment of TSC-22 expression levels and tumor formation after ectopic expression.
  • Evaluation of HPC proliferation and repopulation following TSC-22 gene disruption.

Main Results:

  • TSC-22 promoter methylation was observed in mouse T or NK LGL leukemia, correlating with gene silencing.
  • 5-aza-2'-deoxycytidine therapy reversed TSC-22 deregulation and significantly improved mouse survival.
  • Ectopic TSC-22 expression delayed tumor formation in leukemia and lymphoma models.
  • Targeted TSC-22 disruption enhanced HPC proliferation and repopulation efficiency.

Conclusions:

  • TSC-22 functions as a tumor suppressor gene in T or NK LGL leukemia.
  • Hypermethylation and silencing of TSC-22 contribute to leukemia development.
  • Reversing TSC-22 silencing is a potential therapeutic strategy for LGL leukemia.
  • TSC-22 plays a role in regulating hematopoietic precursor cell function.

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...